Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Chenyu Mao"'
Autor:
Mingyu Wan, Yongfeng Ding, Xiaolu Ma, Xiaoyu Chen, Xin Xu, Chenyu Mao, Jiong Qian, Cheng Xiao, Haiping Jiang, Yulong Zheng, Lisong Teng, Nong Xu
Publikováno v:
Cancer Medicine, Vol 12, Iss 19, Pp 19656-19666 (2023)
Abstract Background Notwithstanding that the past decade has witnessed unprecedented medical progress, gastric cancer (GC) remains a leading cause of cancer death, highlighting the need for effective prognostic markers. The Memorial Sloan Kettering P
Externí odkaz:
https://doaj.org/article/e1c1597280b245d88396c8ad4f2fb868
Autor:
Xiaolu Ma, Yongfeng Ding, Jiong Qian, Mingyu Wan, Ning Li, Chenyu Mao, Cheng Xiao, Haiping Jiang, Yulong Zheng, Luntao Wu, Xiaoyu Chen, Nong Xu
Publikováno v:
Current Oncology, Vol 29, Iss 11, Pp 8937-8954 (2022)
Background. Chemoimmunotherapy has become the first-line treatment for unresectable esophageal squamous cell carcinoma (ESCC). Still, reliable biomarkers to identify patients who could benefit from this combined therapy remain uncertain. This study f
Externí odkaz:
https://doaj.org/article/29d25d7196464b92bb0bf2a881308e31
Autor:
Mingyu Wan, Yongfeng Ding, Chenyu Mao, Xiaolu Ma, Ning Li, Cheng Xiao, Jiong Qian, Haiping Jiang, Yulong Zheng, Luntao Wu, Lisong Teng, Nong Xu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThe emergence of immune checkpoint inhibitors has changed the landscape of first-line treatment of patients with advanced gastric cancer. Currently, the prognostic significance of inflammatory markers in first-line immunotherapy combined wi
Externí odkaz:
https://doaj.org/article/de38fb5ac83b4079b8be85302d77ad2e
Autor:
Weizheng Liang, Junli He, Chenyu Mao, Chengwei Yu, Qingxue Meng, Jun Xue, Xueliang Wu, Shanliang Li, Yukai Wang, Hongyang Yi
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Animal models play a key role in life science research, especially in the study of human disease pathogenesis and drug screening. Because of the closer proximity to humans in terms of genetic evolution, physiology, immunology, biochemistry, and patho
Externí odkaz:
https://doaj.org/article/5e2a5bcd0f5f4572bb2c29977da19a9b
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Macrophages are a population of immune cells functioning in antigen presentation and inflammatory response. Research has demonstrated that macrophages belong to a cell lineage with strong plasticity and heterogeneity and can be polarized into differe
Externí odkaz:
https://doaj.org/article/5c4c88546bbd4f3b8028caf1e6cb6aa8
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Accumulating evidence indicates that RNA methylation, as the most common modification of mRNA, is of great significance in tumor progression and metastasis. Colorectal cancer is a common malignant tumor of the digestive system that seriously affects
Externí odkaz:
https://doaj.org/article/8d972c7919df4c28abb14808d4b7b1bd
Publikováno v:
PLoS ONE, Vol 17, Iss 3, p e0264849 (2022)
Myostatin (MSTN) negatively regulates muscle development and positively regulates metabolism through various pathways. Although MSTN function in cattle has been widely studied, the changes in the gut microbiota due to MSTN mutation, which contribute
Externí odkaz:
https://doaj.org/article/daffe4eec2bb45d3b8cf297265611bfa
Autor:
Haiping Jiang, Yulong Zheng, Jiong Qian, Chenyu Mao, Xin Xu, Ning Li, Cheng Xiao, Huan Wang, Lisong Teng, Hui Zhou, Shuyan Wang, Donglei Zhu, Bo Peng, Lin Shen, Nong Xu
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Sintilimab blocks the interaction between programmed death-1 (PD-1) and its ligands. The safety and efficacy of sintilimab combined with oxaliplatin/capecitabine (CapeOx) as first-line treatment were evaluated in patients with gas
Externí odkaz:
https://doaj.org/article/d2b3ceefa0024cee91685ee7edd4f9a7
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Prostate cancer (PC) is one of the most common malignancies among men and is the second leading cause of cancer death. PC immunotherapy has taken relatively successful steps in recent years, and these treatments are still being developed and tested.
Externí odkaz:
https://doaj.org/article/2a057f2f4e9240d7af897d40afe50b31
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Bladder cancer (BC) is the ninth most common cancer and the thirteenth most common cause of mortality worldwide. Bacillus Calmette Guerin (BCG) instillation is a common treatment option for BC. BCG therapy is associated with the less adversary effect
Externí odkaz:
https://doaj.org/article/75f72e120c9e40eeaae07726f2d55d5e